Últimas noticias sobre Cue Biopharma (NASDAQ:CUE) Bolsa

Cue Biopharma

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Cue Biopharma Inc

Cuentas Inc

COPPEREX RES CORP by COPPEREX RES CORP

CUE ENERGY RESOURCES LTD by Cue Energy Resources Ltd.

Barclays analyst Raimo Lenschow maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Overweight and raises the price target from $202 to $221.

News

Price Target

Analyst Ratings

ORCL

Barclays Maintains Overweight on Oracle, Raises Price Target to $221

Cryptocurrency markets traded lower early Friday as rising geopolitical tensions between Israel and Iran rattled investor sentiment. Bitcoin broke below key support levels, but accumulation continues, with wallets adding <a href="https://www.benzinga.com/topic/bitcoin">BTC during the dip.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$104,708.95</td>
<td>-2.4%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,524.73</td>
<td>-8%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$144.27</td>
<td>-9.2%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.13</td>
<td>-4.6%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1741</td>
<td>-7.5%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001169</td>
<td>-7.4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows that Bitcoin and Ethereum&#8217;s large transaction volume decreased 16% and 6.6%, respectively. However, daily active addresses witnessed an increase of 3.8% and 1.4% each in a single day.</li>
<li>Coinglass data shows 248,509 traders were liquidated in the past 24 hours with the total liquidations at $1.16 billion.</li>
<li>SoSoValue data shows net inflows of $164.6 million into spot Bitcoin ETFs while Spot Ethereum ETFs saw net inflows of $112.4 million.</li>
<li>CryptoQuant founder and CEO Ki Young Ju <a href="https://x.com/ki_young_ju/status/1933430511592223175">noted </a>that Bitcoin long term holders have added 881,578 BTC over the past 30 days.</li>
</ul>
Trader Notes: Degen Hardy noted that Bitcoin has retraced into a macro range between $101,000–$110,000, with potential long entry zones at $96,000 and $91,000–$92,000. He advises traders to remain patient as the market develops.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> UPDATE Price has dropped back into the macro range but with a local range of $101K &#8211; $110K. There is a possibility that the bulls can hold here but my main zones of interest to look for longs remains the same: -$96K -$91K/$92K Lets see what the day brings us and the… <a href="https://t.co/HRiCT5OvXZ">pic.twitter.com/HRiCT5OvXZ</a>
&mdash; Hardy (@Degen_Hardy) <a href="https://twitter.com/Degen_Hardy/status/1933409785430577436?ref_src=twsrc%5Etfw">June 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Michael van de Poppe commented that Ethereum&#8217;s drop was sharper than expected, but the strategy remains unchanged: buy the dip. He sees the move as temporary and believes the same approach applies to Bitcoin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A little bit deeper than <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> &#8211;&gt; Yikes. Anyways, same concept. Buying the dip for opportunities. This should quickly fade away. <a href="https://t.co/Kp7mC6ZWTx">pic.twitter.com/Kp7mC6ZWTx</a>
&mdash; Michaël van de Poppe (@CryptoMichNL) <a href="https://twitter.com/CryptoMichNL/status/1933461089292890623?ref_src=twsrc%5Etfw">June 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto Daily Trade Signals <a href="https://x.com/cryptodailyTS/status/1933460542003556599">flagged</a> the continued legal overhang from the Ripple vs. SEC case as a drag on XRP. Despite recent partial wins, the unresolved litigation adds uncertainty, especially for U.S. traders, but the long-term outlook remains positive if Ripple expands its global remittance footprint.
On Solana, Andrew Griffiths <a href="https://x.com/AndrewGriUK/status/1933436346460180636">pointed</a> out a pullback to the $144–$145 demand zone, a structurally important level. He set a stop-loss at $139.20, with potential upside targets at $160.65, $168.22, and $179.32, assuming buyers regain control.
Trader Tardigrade <a href="https://x.com/TATrader_Alan/status/1933450284266893456">highlighted</a> a Rate of Change (ROC) breakout on Dogecoin, comparable to the setup seen ahead of its 2021 bull run. He suggests DOGE may be poised for another strong upward move.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45902384/ethereum-etfs-outpace-bitcoin-etfs-with-240m-inflows-on-june-11">Ethereum ETFs Outpace Bitcoin ETFs With $240M Inflows On June 11</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Slump In The Aftermath Of Israel-Iran Tensions

Barclays analyst Gaurav Jain maintains Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) with a Overweight and raises the price target from $205 to $220.

Barclays Maintains Overweight on Philip Morris Intl, Raises Price Target to $220

Arm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) CEO&nbsp;Rene Haas&nbsp;condemned the <a target="_blank" href="https://www.benzinga.com/topic/semiconductors" rel="noreferrer noopener">U.S. sanctions on</a> China in tandem with Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chief Jensen Huang. He said it would compromise overall technological advances and impact consumers and companies.
Haas discussed the repercussions of restricting access to technology in the ecosystem <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-06-12/arm-ceo-sides-with-nvidia-against-us-export-limits-on-china?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">to</a> Bloomberg on Thursday at the Founders Forum Global conference in Oxford.
He emphasized Arm&#8217;s significant footprint in China.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45903304/xpeng-says-its-new-self-driving-chip-is-3x-more-powerful-than-nvidias-will-power-vw-cars" rel="noreferrer noopener">Xpeng Says Its New Self-Driving Chip Is 3x More Powerful Than Nvidia&#8217;s, Will Power VW Cars</a>
President&nbsp;Donald Trump confirmed&nbsp;the China trade deal on Thursday&nbsp;after two days of negotiations in London. The U.S. said it will continue applying 55% tariffs on selected Chinese imports, while China will impose a 10% tariff rate on U.S. goods.
Haas acknowledged Nvidia&#8217;s moat while expressing conviction on Arm&#8217;s range of edge, from training and inference in the data center to running something as small as earbuds.
The semiconductor companies warned against the Nvidia sanctions, which could prompt China to develop its industry and, thus, harm the U.S.
Haas said Chinese competitors have evolved, citing the example of Huawei Technologies Co.&nbsp;The Trump administration had blacklisted Huawei in 2019, citing national security threats.
The 2020 pandemic further disrupted supply chains, triggering the global semiconductor chip crisis. It prompted countries to reduce their dependence on China and boost their domestic semiconductor positions instead.
In April, the Trump administration imposed sanctions on exports of data center processors to Chinese customers, which cost Nvidia about $8 billion in Chinese revenue during its second fiscal quarter.
Washington and Beijing ended the latest trade negotiations this week, with&nbsp;Donald Trump&nbsp;declaring a deal to restore the flow of critical metals from China.
Price Actions: ARM stock is down by 1.53% at $136.50 premarket at last check Friday. NVDA is down 2.1%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45906594/micron-and-trump-announce-200-billion-us-chip-expansion-plan-aiming-to-create-90k-jobs" target="_blank" rel="noreferrer noopener">Micron And Trump Announce $200-Billion US Chip Expansion Plan, Aiming To Create 90K Jobs</a></li>
</ul>
Photo by Maxx-Studio via Shutterstock

Tech

Media

NVDA

Arm CEO Warns Chip Sanctions On China Are Counterproductive For USA

As of June 13, 2025, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Matador Resources Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTDR#NYSE">MTDR</a>)</h3>
<ul class="wp-block-list">
<li>On June 12, Matador Resources promoted William Lambert to EVP, CFO and Head of Strategy. The company's stock jumped around 9% over the past five days and has a 52-week high of $66.89.</li>
<li>RSI Value: 70.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MTDR Price Action: Shares of Matador Resources gained 1% to close at $49.50 on Thursday.</li>
<li>Edge Stock Ratings: 23.17 Momentum score with Value at 90.25. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/mtdr"><img loading="lazy" decoding="async" width="422" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13010316/image-211.png" alt="" class="wp-image-948465" style="width:326px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13010316/image-211.png 422w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13010316/image-211-300x122.png 300w" sizes="(max-width: 422px) 100vw, 422px" /></a></figure>
<h3 class="wp-block-heading">TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>)</h3>
<ul class="wp-block-list">
<li>On April 30, TotalEnergies reported first-quarter adjusted EPS of $1.83, down 15% year over year (Y/Y), and missed the consensus of $1.88. For the second quarter of FY25, the company anticipates hydrocarbon production to 2% to 3% Y/Y, with an impact from more planned maintenance than during the first quarter of 2025 (50 kboe/d) and second quarter of 2024. The company anticipates the average LNG selling price to be between $9 and $9.5/Mbtu in the second quarter of 2025. The company's stock gained around 7% over the past five days and <a href="https://www.benzinga.com/quote/TTE">has a 52-week high</a> of $71.03.</li>
<li>RSI Value: 70.4</li>
<li>TTE Price Action: Shares of TotalEnergies gained 1.6% to close at $63.07 on Thursday.</li>
</ul>
Learn more about BZ Edge Rankings—click to see scores for other <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">stocks in the sector and see how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

MTDR

Top 2 Energy Stocks That May Fall Off A Cliff in June

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Roger Song downgraded the rating for CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) from Buy to Hold and lowered the price target from $7 to $5. CureVac shares closed at $5.60 on Thursday. <a href="https://www.benzinga.com/quote/CVAC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Patrick Cunningham downgraded The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Buy to Neutral and lowered the price target from $405 to $385. Sherwin-Williams shares closed at $356.20 on Thursday. <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Turrin downgraded Dayforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>) from Equal-Weight to Underweight and cut the price target from $60 to $50. Dayforce shares closed at $59.59 on Thursday. <a href="https://www.benzinga.com/quote/DAY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Turrin downgraded the rating for ZoomInfo Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTM#NASDAQ">GTM</a>) from Equal-Weight to Underweight and slashed the price target from $10 to $9. ZoomInfo shares closed at $9.99 on Thursday. <a href="https://www.benzinga.com/quote/GTM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying SHW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SHW/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="570" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083750/image-222-1024x570.png" alt="" class="wp-image-948991" style="width:652px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083750/image-222-1024x570.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083750/image-222-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083750/image-222-768x427.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083750/image-222.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Downgrades

CVAC

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

JP Morgan analyst Anthony Paolone maintains Piedmont Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) with a Neutral and lowers the price target from $9 to $8.

JP Morgan Maintains Neutral on Piedmont Realty Trust, Lowers Price Target to $8

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/06/12/final-trades-jabil-sofi-and-kinsale-capital.html">Halftime Report Final Trades</a>,&#8221; Malcolm Ethridge, executive vice president of CIC Wealth Management, named SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) as his final trade.
SoFi, on April 29, reported quarterly adjusted sales of $770.72 million, beating analyst estimates of $739.04 million. The company reported quarterly adjusted earnings of 6 cents per share, beating analyst estimates of 4 cents per share
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Kevin Simpson, CIO of Capital Wealth Planning, said Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) surged to a 52-week high on Thursday in the <a href="https://www.benzinga.com/quote/JBL/earnings">AI infrastructure wave</a>.
On the earnings front, Jabil will release its third quarter of fiscal year financial results on Tuesday, June 17, before the opening bell. Analysts expect the Saint Petersburg, Florida-based company to report quarterly earnings at $2.30 per share, up from $1.89 per share in the year-ago period. Jabil projects to report quarterly revenue at $7.03 billion, compared to $6.76 billion a year earlier, according to data from Benzinga Pro.
Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Kinsale Capital Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) as his final trade.
Supporting his view, Morgan Stanley analyst Bob Huang, on May 19, maintained Kinsale Capital with an Overweight rating and raised the price target from $490 to $525.
Price Action:
<ul class="wp-block-list">
<li>Jabil shares rose 0.4% to close at $179.08 on Thursday.</li>
<li>SoFi shares fell 1.1% to settle at $14.90 during the session.</li>
<li>Kinsale Capital shares gained 3.1% to settle at $473.94 during the session.</li>
</ul>
Check This Out:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Image: Shutterstock

Analyst Color

Long Ideas

KNSL

SOFI

SoFi Technologies, Jabil And A Financial Stock On CNBC's 'Final Trades'

JP Morgan analyst Michael Mueller maintains Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) with a Neutral and raises the price target from $160 to $162.

JP Morgan Maintains Neutral on Extra Space Storage, Raises Price Target to $162

Safety Shot, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOT#NASDAQ">SHOT</a>) ("Safety Shot" or the "Company"), a wellness and dietary supplement company, today announced that it a majority of its shareholders have voted by a majority to approve the proposed acquisition of Yerbaé Brands Corp. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/YERB#TSXV">YERB</a>) ("Yerbaé"), a plant-based functional beverage company.
The approval was obtained at Safety Shot's Special Meeting of Stockholders held earlier yesterday. Following the completion of the merger, which is expected to occur next week, the combined company will continue to operate under the name Safety Shot, Inc., and its common stock will continue to trade on The Nasdaq Capital Market under the ticker symbol "SHOT". Upon closing, Yerbaé's shares will be delisted from the TSX Venture Exchange.

SHOT

SHOTW

TSXV:YERB

Safety Shot Says Majority Of Its Shareholders Vote To Approve Proposed Acquisition Of Yerbaé Brands

<a href="https://www.globenewswire.com/Tracker?data=qsMVfJzWwZ5fJ9j1qVNWC2tow9oAxISSRpO0RTLFmgKZ6lz6eJWhCpLDOPdKqMgtdX3_Onsj4YZ8BRSdXYBK1g==">Viasat, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>), a global leader in satellite communications, today announced that its subsidiary Inmarsat Global Ltd. ("Inmarsat") has agreed to a binding term sheet with Ligado Networks ("Ligado") and AST &amp; Science, LLC ("AST") to settle Inmarsat's opposition to Ligado's planned restructuring. Under the conditions set forth in the term sheet, Viasat anticipates receiving $568 million from Ligado in fiscal year 2026, which will primarily be used to manage near term maturities and address its extended maturity profile.
Under the conditions of the term sheet, and subject to Bankruptcy Court approval, Inmarsat, Ligado and AST agreed to the following:
<ul>
<li>Starting on September 30, 2025, Ligado will resume making quarterly payments of ~$16 million per quarter to Inmarsat.&nbsp;The quarterly payment amount increases 3% per year for the life of the contract (through 2107).</li>
<li>Ligado will make a $420 million lump sum payment to Inmarsat on October 31, 2025.</li>
<li>Ligado will pay a lump sum payment of $100 million to Inmarsat on March 31, 2026. Including the December and March quarterly payments, Inmarsat expects to receive a total of $568 million by March 31, 2026.</li>
<li>Ligado's lawsuit against Inmarsat is stayed effective immediately and will be dismissed under conditions set forth in the term sheet.</li>
<li>Viasat's considerable ability to provide essential mobile satellite services (MSS) globally remains unaffected. The agreement reflects Viasat's continued commitment to facilitate innovation that enables new MSS services while ensuring the interference-free provision of existing services, including vital safety services. The agreement also demonstrates the ability to introduce new satellite configurations within existing spectrum sharing terms that have provided critical stability in the industry for decades.</li>
</ul>

VSAT

Viasat Subsidiary Inmarsat Agrees To Binding Term Sheet With Ligado Networks And AST & Science To Settle Inmarsat's Opposition To Ligado's Planned Restructuring

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Canaccord Genuity analyst George Gianarikas initiated coverage on USA Rare Earth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) with a Buy rating and announced a price target of $17. USA Rare Earth shares closed at $14.53 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Avinatan Jaroslawicz initiated coverage on EMCOR Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) with a Buy rating and announced a price target of $570. EMCOR Group shares closed at $474.93 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Finian O&#8217;Shea initiated coverage on Blue Owl Technology Finance Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTF#NYSE">OTF</a>) with an Equal-Weight rating and announced a price target of $15. Blue Owl Technology Finance shares closed at $16.56 on Thursday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying EME stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/EME/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083017/image-221-1024x598.png" alt="" class="wp-image-948971" style="width:649px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083017/image-221-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083017/image-221-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083017/image-221-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13083017/image-221.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Initiation

USAR

This EMCOR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

Unusual Machines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#NYSE">UMAC</a>), a leader in drone technology and component manufacturing, today announced that it has notified Aloft that the previously announced acquisition has been terminated, effective June 9, 2025, in accordance with the termination provisions of the definitive agreement, as amended.
The decision was made after careful consideration and reflects recognition that the transaction, as structured, no longer aligns with the strategic priorities of either organization. No termination fees will be incurred, and both companies remain open to exploring future collaborations.
Unusual Machines' business outlook remains unchanged, with no anticipated impact to operations, cash position, or strategic initiatives because of the canceled transaction.

UMAC

Unusual Machines Terminates Definitive Agreement To Acquire Aloft; Unusual Machines' Business Outlook Remains Unchanged

Bernstein analysts have identified the tokenization of real-world assets (RWAs) as a transformative trend that could reshape global finance, outlining how <a href="https://www.benzinga.com/topic/tokenization">blockchain-based tokenized markets</a>, though still early in development, are on track to become a multi-trillion dollar industry as infrastructure and regulatory clarity improve.
The report describes tokenization as "the next generation of market infrastructure," citing its potential to improve settlement processes, reduce counterparty risks, and broaden access to traditionally illiquid assets such as private credit and real estate.
Bernstein sees early evidence of this shift in pilot programs, where traditional financial institutions are exploring blockchain infrastructure for settlements, repo, and collateralization. 
"Tokenization is not just about converting real world assets into tokens. It is about a better market infrastructure design — faster settlements, improved transparency, lower costs, and inclusion of a larger base of global investors," the analysts wrote.
The firm highlights the role of stablecoins and tokenized treasury bills as early product-market fits, offering the benefits of on-chain liquidity and efficiency while integrating with real-world financial systems. 
"The adoption of blockchain-based infrastructure in the financial sector is no longer a theoretical concept — it's underway," the report states.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45912870/gamestops-bitcoin-strategy-draws-skepticism-amid-1-75b-debt-offering">GameStop&#8217;s Bitcoin Strategy Draws Skepticism Amid $1.75B Debt Offering</a>
While public blockchain infrastructure continues to evolve, Bernstein suggests that private-permissioned environments may lead to early institutional experiments.
Eventually, however, these use cases could migrate to more decentralized platforms as technology and compliance tools mature.
The report emphasizes the scale of the opportunity by noting the size of underlying traditional markets, including $8 trillion in private credit, $4 trillion in real estate, and trillions more in trade finance and other asset classes. 
"The opportunity in RWA tokenization lies in solving the market infrastructure challenges," the report says, citing improvements in custody, compliance, and identity solutions as critical enablers.
The analysts also suggest that sovereign wealth funds, banks, and asset managers are showing increasing interest in this space, attracted by the combination of on-chain programmability and compliance.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45904219/bitcoin-gold-stocks-is-the-best-portfolio-to-fight-inflation-billionaire-paul-tudor-jones-says">Bitcoin, Gold, Stocks Is The Best Portfolio To Fight Inflation, Billionaire Paul Tudor Jones Says</a></li>
</ul>
Photo: Shutterstock

Tokenization Could Unlock Trillions: Bernstein Calls It Next-Gen Infrastructure

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and maintains $16 price target.

BMEA

D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $16 Price Target

SNES

Senestech Says City Of Baltimore Concludes Initial Pilot Program And Now Transitions To Broader Deployment Of Evolve, Non-Lethal Rodent Birth Control Products

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.28%</li>
<li>B of A Securities analyst Bryan Spillane downgraded the stock from Neutral to Underperform and cut the price target from $27 to $20 on June 12, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Goldman Sachs analyst Leah Jordan downgraded the stock from Neutral to Sell and slashed the price target from $26 to $21 on June 9, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: Conagra Brands will release its fiscal 2025 fourth quarter and full year results on Thursday, July 10.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest CAG <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613"><img loading="lazy" decoding="async" width="892" height="670" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13011939/image-213.png" alt="" class="wp-image-948484" style="width:654px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13011939/image-213.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13011939/image-213-300x225.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13011939/image-213-768x577.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.81%</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and increased the price target from $46 to $49 on May 2, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Stifel analyst Matthew Smith maintained a Buy rating and increased the price target from $60 to $63 on April 30, 2024. This analyst has an accuracy rate of 60%.</li>
<li>Recent News: On April 29, Altria Group posted upbeat quarterly earnings.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest MO <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613"><img loading="lazy" decoding="async" width="916" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012020/image-214.png" alt="" class="wp-image-948485" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012020/image-214.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012020/image-214-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012020/image-214-768x706.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Energizer Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.55%</li>
<li>Barclays analyst Lauren Lieberman maintained an Equal-Weight rating and raised the price target from $25 to $26 on May 16, 2025. This analyst has an accuracy rate of 61%.</li>
<li>JP Morgan analyst Andrea Teixeira maintained a Neutral rating and lowered the price target from $36 to $30 on April 11, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On May 6, Energizer Holdings reported in-line earnings for the second quarter.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest ENR <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0613"><img loading="lazy" decoding="async" width="912" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012102/image-215.png" alt="" class="wp-image-948487" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012102/image-215.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012102/image-215-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13012102/image-215-768x716.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Dividends

Wall Street's Most Accurate Analysts Give Their Take On 3 Risk Off Stocks Delivering High-Dividend Yields

Small Cap Consumer Research analyst Eric Beder reiterates Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) with a Buy and maintains $20 price target.

Reiteration

Small Cap Consumer Research Reiterates Buy on Lands' End, Maintains $20 Price Target

U.S. stock futures were lower this morning, with the Dow futures falling more than 500 points on Friday.
Shares of Adobe Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) fell in today's pre-market trading after the company reported second-quarter financial results and <a href="https://www.benzinga.com/quote/ADBE/earnings">raised its FY25 guidance</a>.
The company reported second-quarter revenue of $5.87 billion, beating analyst estimates of $5.79 billion, according to Benzinga Pro. The company reported second-quarter adjusted earnings of $5.06 per share, surpassing the estimated $4.96 per share.
Adobe slipped 1.8% to $406.55 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares tumbled 16.2% to $17.03 in pre-market trading after jumping over 82% on Thursday.</li>
<li>The Generation Essentials Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGE#NYSE">TGE</a>) fell 10.6% to $8.46 in pre-market trading after dipping 14% o Thursday.</li>
<li>VEON Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) shares dipped 9.9% to $42.36 in pre-market trading after jumping 5% on Thursday.</li>
<li>Arrive AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) fell 8.8% to $8.50 in pre-market trading after gaining around 10% on Thursday. Arrive AI recently announced it obtained another patent for its AI-powered smart mailbox platform designed for autonomous and conventional package delivery.</li>
<li>SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) fell 7.3% to $3.94 in pre-market trading.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) fell 7.1% to $5.07 in pre-market trading. The company, on Thursday, announced a seven-figure NATO contract for daily monitoring and intelligence capabilities.</li>
<li>Omada Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMDA#NASDAQ">OMDA</a>) dipped 6.8% to $16.00 in pre-market trading.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) fell 6% to $4.2500 in pre-market trading.</li>
<li>FibroGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) fell 4.4% to $0.2949 in pre-market trading as the company reported a 1-for-25 reverse stock split.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a></li>
</ul>
Photo via Shutterstock

Movers

ADBE

ARAI

CMPS

FGEN

LAES

LIMN

OMDA

VEON

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Steve Barger upgraded Myers Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) from Sector Weight to Overweight and announces $21 price target. Myers shares closed at $14.54 on Thursday. <a href="https://www.benzinga.com/quote/mye/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Andy Barish upgraded the rating for Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) from Underperform to Hold and raised the price target from $165 to $210. Darden shares closed at $217.81 on Thursday. <a href="https://www.benzinga.com/quote/dri/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Andrea Teixeira upgraded Newell Brands Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) from Neutral to Overweight and raised the price target from $6 to $7. Newell Brands shares closed at $5.43 on Thursday. <a href="https://www.benzinga.com/quote/nwl/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Andrew Nowinski upgraded Zscaler, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) from Equal-Weight to Overweight and raised the price target from $260 to $385. Zscaler shares closed at $301.43 on Thursday. <a href="https://www.benzinga.com/quote/zs/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Turrin upgraded DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) from Underweight to Equal-Weight and boosted the price target from $67 to $80. Docusign shares closed at $76.01 on Wednesday. <a href="https://www.benzinga.com/quote/docu/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying DRI stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/DRI/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="530" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13081847/image-220-1024x530.png" alt="" class="wp-image-948951" style="width:645px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13081847/image-220-1024x530.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13081847/image-220-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13081847/image-220-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/13081847/image-220.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a></li>
</ul>
Photo via Shutterstock

Comments

Cue Biopharma

Noticias

Últimas noticias sobre Cue Biopharma (NASDAQ:CUE) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL